Form 8-K - Current report:
SEC Accession No. 0001558370-21-013308
Filing Date
2021-10-20
Accepted
2021-10-20 13:09:10
Documents
15
Period of Report
2021-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20211015x8k.htm   iXBRL 8-K 40317
2 EX-99.1 ganx-20211015xex99d1.htm EX-99.1 11574
3 GRAPHIC ganx-20211015xex99d1002.jpg GRAPHIC 13267
  Complete submission text file 0001558370-21-013308.txt   233675

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20211015.xsd EX-101.SCH 3272
5 EX-101.DEF ganx-20211015_def.xml EX-101.DEF 13301
6 EX-101.LAB ganx-20211015_lab.xml EX-101.LAB 20451
7 EX-101.PRE ganx-20211015_pre.xml EX-101.PRE 14137
8 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20211015x8k_htm.xml XML 6952
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 211333481
SIC: 2834 Pharmaceutical Preparations